Minimal residual disease monitoring in multiple myeloma: flow cytometry is the method of choice

被引：15
|
作者：
Owen, RG [1 ]
Rawstron, AC [1 ]
机构：
[1] Leeds Teaching Hosp NHS Trust, HMDS Lab, Leeds, W Yorkshire, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2005年 / 128卷 / 05期
关键词：
minimal residual disease; myeloma; flow cytometry;
D O I：
10.1111/j.1365-2141.2005.05376.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：732 / 733
页数：3
相关论文
共 50 条
  • [1] MINIMAL RESIDUAL DISEASE MONITORING IN MULTIPLE MYELOMA USING POLYCHROMATIC FLOW CYTOMETRY
    Rihova, Lucie
    Varmuzova, Tamara
    Zarbochova, Pavla
    Suska, Renata
    Penka, Miroslav
    Hajek, Roman
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2012, 82B (06) : 404 - 405
  • [2] Reliable monitoring of minimal residual disease in multiple myeloma:: how specific is flow cytometry?
    Lioznov, MV
    Cortes-Dericks, L
    Fehse, B
    Zander, AR
    Kröger, N
    BONE MARROW TRANSPLANTATION, 2006, 37 : S146 - S147
  • [3] Minimal residual disease in multiple myeloma: Benefits of flow cytometry
    Galtseva, I. V.
    Davydova, Y. O.
    Kapranov, N. M.
    Julhakyan, H. L.
    Mendeleeva, L. P.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (01) : 12 - 20
  • [4] MINIMAL RESIDUAL DISEASE MONITORING IN MULTIPLE MYELOMA PATIENTS BY FLOW CYTOMETRY: A SINGLE CENTER EXPERIENCE
    Sizikova, S.
    Pronkina, N.
    Batorov, E.
    Ushakova, G.
    Sergeevicheva, V.
    Gilevich, A.
    Kruchkova, I.
    HAEMATOLOGICA, 2017, 102 : 789 - 789
  • [5] Clinical implication of minimal residual disease monitoring by 10-color flow cytometry in multiple myeloma
    姚卫芹
    ChinaMedicalAbstracts(InternalMedicine), 2019, 36 (04) : 231 - 232
  • [6] Flow cytometry immunophenotype is a powerful approach in monitoring minimal residual disease and treatment efficacy in multiple myeloma
    Cordone, I.
    Masi, S.
    Pasquale, A.
    Pisani, F.
    Olimpieri, O. M.
    Marino, M.
    D'Andrea, M.
    Dessanti, M. L.
    Petti, M. C.
    CYTOMETRY PART A, 2008, 73A (01) : 79 - 79
  • [7] Monitoring of minimal residual disease in multiple myeloma:: Flow cytometry vs PCR-based techniques
    Lioznov, M.
    Badbaran, A.
    Fehse, B.
    Zander, A.
    Kroeger, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 203 - 203
  • [8] Minimal Residual Disease Detection by Flow Cytometry in Multiple Myeloma: Why and How?
    Roshal, Mikhail
    SEMINARS IN HEMATOLOGY, 2018, 55 (01) : 4 - 12
  • [9] Regulatory Perspective on Minimal Residual Disease Flow Cytometry Testing in Multiple Myeloma
    Gormley, Nicole J.
    Turley, Danielle M.
    Dickey, Jennifer S.
    Farrell, Ann T.
    Reaman, Gregory H.
    Stafford, Elizabeth
    Carrington, Lea
    Marti, Gerald E.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2016, 90 (01) : 73 - 80
  • [10] Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity
    Flanders, Aaron
    Stetler-Stevenson, Maryalice
    Landgren, Ola
    BLOOD, 2013, 122 (06) : 1088 - 1089
12345